NCT00134641View on ClinicalTrials.gov

Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Sarcoma, Soft Tissue
Interventions
DRUG

gemcitabine

DRUG

vinorelbine

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00134641 - Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas | Biotech Hunter | Biotech Hunter